EMEA-001797-PIP01-15-M01
Key facts
| Active substance |
Human normal immunoglobulin
|
| Therapeutic area |
Immunology-Rheumatology-Transplantation
|
| Decision number |
P/0021/2018
|
| PIP number |
EMEA-001797-PIP01-15-M01
|
| Pharmaceutical form(s) |
Solution for injection
|
| Condition(s) / indication(s) |
Treatment of Primary Immunodeficiency (PID)
|
| Route(s) of administration |
Subcutaneous use
|
| Contact for public enquiries |
Octapharma Pharmazeutika Produktionsges.m.b.H
Tel. +43 1610 321201
E-mail: wolfgang.frenzel@octapharma.com |
| Decision type |
PM: decision on the application for modification of an agreed PIP
|
| Compliance procedure number |
EMEA-C-001797-PIP01-15-M01
|
| Compliance opinion date |
21/09/2018
|
| Compliance outcome |
positive
|